ArticleCancers2024

Functional Assessments of Gynecologic Cancer Models Highlight Differences Between Single-Node Inhibitors of the PI3K/AKT/mTOR Pathway and a Pan-PI3K/mTOR Inhibitor, Gedatolisib.

Aaron Broege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.